Amar Hadzic, MSc1,2,3*, Maria Garcia-Marquez, PhD4,5*, David M. Cordas dos Santos, MD1,3,6*, Martin E. Kirmaier, PhD1,3,6*, Pol Bannasch, MSc1,6*, Nina Haindl, MSc1,6*, Sabine Oganesian, MSc1,3,6*, Maximilian A Funk, MD, PhD1,3,6*, Anneli Tischmacher, BSc1,6*, Katharina Frey, MSc1,6*, Ludovica Vona1,3,6*, Adriano Carboniero, MSc1,3,6*, Jingke Tu, MD1,3,6*, Michael Von Bergwelt, MD, PhD1,3,6,7,8 and Sebastian Theurich, MD1,3,6,7,8*
1Department of Medicine III, University Hospital Munich (LMU), Munich, Germany
2Cancer- and Immunometabolism Research Group, LMU Gene Center, München, Germany
3German Cancer Consortium (DKTK), Partner Site Munich, Munich, Germany
4Department of General, Visceral, Cancer and Transplantation Surgery, University of Cologne, Cologne, Germany
5Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany
6Cancer- and Immunometabolism Research Group, LMU Gene Center, Munich, Germany
7Bavarian Cancer Research Center (BZKF), Munich, Germany
8Comprehensive Cancer Center Munich, LMU University Munich, Munich, Germany